Lord, Abbett & Co. LLC Edwards Lifesciences Corp Transaction History

Lord, Abbett & Co. LLC

$30.7 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $107 Million - $140 Million	-1,300,714 Reduced 94.68%	73,020 $6.03 Million
Q2 2022 Aug 12, 2022	BUY	$86.5 - $128.27 $5.25 Million - $7.78 Million	60,686 Added 4.62%	1,373,734 $131 Million
Q1 2022 May 13, 2022	BUY	$101.96 - $128.34 $42.7 Million - $53.8 Million	419,157 Added 46.89%	1,313,048 $155 Million
Q4 2021 Feb 11, 2022	SELL	$106.37 - $130.68 $72.8 Million - $89.5 Million	-684,749 Reduced 43.38%	893,891 $116 Million
Q3 2021 Nov 09, 2021	BUY	$102.91 - $122.75 $103 Million - $122 Million	996,051 Added 170.97%	1,578,640 $179 Million
Q2 2021 Aug 11, 2021	BUY	$83.84 - $104.76 $48.8 Million - $61 Million	582,589 New	582,589 $60.3 Million
Q1 2020 May 14, 2020	SELL	$52.41 - $81.0 $4.68 Million - $7.23 Million	-89,231 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$71.7 - $82.09 $5.62 Million - $6.43 Million	-78,369 Reduced 46.76%	89,231 $20.8 Million
Q3 2019 Nov 14, 2019	BUY	$61.55 - $75.43 $9.14 Million - $11.2 Million	148,519 Added 778.36%	167,600 $36.9 Million
Q2 2019 Aug 14, 2019	SELL	$55.74 - $64.41 $8.74 Million - $10.1 Million	-156,816 Reduced 89.15%	19,081 $3.53 Million
Q1 2019 May 15, 2019	SELL	$47.89 - $64.05 $4.65 Million - $6.23 Million	-97,193 Reduced 35.59%	175,897 $33.7 Million
Q4 2018 Feb 14, 2019	BUY	$46.41 - $56.94 $7.93 Million - $9.73 Million	170,902 Added 167.24%	273,090 $41.8 Million
Q3 2018 Nov 14, 2018	SELL	$45.7 - $58.03 $7.45 Million - $9.46 Million	-163,039 Reduced 61.47%	102,188 $17.8 Million
Q2 2018 Aug 14, 2018	BUY	$42.45 - $51.3 $6.46 Million - $7.81 Million	152,162 Added 134.58%	265,227 $38.6 Million
Q1 2018 May 15, 2018	BUY	$37.19 - $47.45 $1.03 Million - $1.31 Million	27,667 Added 32.4%	113,065 $15.8 Million
Q4 2017 Feb 14, 2018	BUY	$33.79 - $39.39 $436,701 - $509,076	12,924 Added 17.83%	85,398 $9.63 Million
Q3 2017 Nov 14, 2017	SELL	$36.29 - $38.83 $408,044 - $436,604	-11,244 Reduced 13.43%	72,474 $7.92 Million
Q2 2017 Aug 14, 2017	BUY	N/A	83,718	83,718 $9.9 Million

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

Vanguard Group Inc Valley Forge, PA

62.6M
Shares

$4.24 Billion
0.08% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.45 Billion
0.11% of portfolio
Wellington Management Group LLP Boston, MA

31.5M
Shares

$2.14 Billion
0.37% of portfolio
State Street Corp Boston, MA

26.3M
Shares

$1.78 Billion
0.07% of portfolio
Geode Capital Management, LLC Boston, MA

13.5M
Shares

$916 Million
0.07% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Account